國家衛生研究院 NHRI:Item 3990099045/9364
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 858403      在线人数 : 480
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/9364


    题名: Effects of antihypertensive therapies on primary and secondary prevention of stroke: Systematic review and network meta-analysis
    作者: Cheng, HM;Wang, WT;Chiang, CE;Sung, SS;You, LK;Chuang, SY;Chen, CH
    贡献者: Division of Health Services and Preventive Medicine
    摘要: Background: Hypertension is the most important risk factor for stroke and stroke recurrence. However, the preferred antihypertensive therapy for these patients has yet to be determined. Methods: We performed a systematic review, network meta-analysis, and metaregression of randomized controlled trials that investigated the effect of antihypertensive therapies on primary prevention of stroke or secondary prevention for previous stroke patients of any vascular event. Trials were identified from searches of published hypertension guidelines, electronic databases, and clinical trial registries. Results: For primary prevention (39 trials, 283529 patients), all antihypertensive agents, except alpha-blocker, outperformed placebo in preventing any stroke events. By using probability ranking for mixed treatment comparisons, angiotension receptor blocker may be the most preferred agent for primary prevention of stroke. For secondary prevention (10 trials, 40496 patients), only diuretics significantly outperformed placebo for preventing any adverse vascular events, and should be the class of choice for patients with previous stroke. Moreover, for primary prevention trials, the meta-regression analysis showed that 1 mmHg decrease of BP was associated with an 0.12% absolute risk reduction of (95% confidence interval 0.061–0.170; p=0.00012) for any stroke. Conclusions: Evidence from randomized controlled trials supports the use of antihypertensive agents in lowering blood pressure for the primary prevention of stroke and secondary prevention of vascular events in patients with previous stroke. Although angiotension receptor antagonist and diuretics may be the most preferred strategies for primary and secondary prevention, repectively, the final achieved BP may be the key element in the effective risk reduction for primary prevention of stroke.
    日期: 2015-08
    關聯: European Heart Journal. 2015 Aug;36(Suppl.1):879.
    Link to: http://dx.doi.org/10.1093/eurheartj/ehv401
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0195-668X&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000361205106107
    显示于类别:[莊紹源] 會議論文/會議摘要

    文件中的档案:

    档案 大小格式浏览次数
    ISI000361205106107.pdf59KbAdobe PDF502检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈